Sunday , 19 January 2025
Home Health Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business
Health

Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business

Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business

In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leverage digital technologies in disease management.

The post Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business appeared first on MedCity News.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

AstraZeneca’s Calquence has expanded its FDA approval to include first-line treatment of...

This interactive chart allows users to track public opinion on the Affordable...

By MIKE MAGEE In case you’ve missed it, sleep is all the...

Teladoc Health has joined Amazon’s Health Benefits Connector. Other companies offered through...